Camzyos (mavacamten)

pCPA File Number: 22344

Negotiation Status:

Active Negotiation

Indication(s):

Treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) of New York Heart Association (NYHA) Class II-III in adult patients.

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CADTH Project Number:

SR0755

pCPA Engagement Letter Issued:

2024-01-15

Negotiation Process Concluded:

Not Applicable